{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:27:14Z","timestamp":1774362434304,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejso.2011.09.002","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T07:45:21Z","timestamp":1316504721000},"page":"31-37","source":"Crossref","is-referenced-by-count":52,"title":["The value of 18-FDG PET\/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan"],"prefix":"10.1016","volume":"38","author":[{"given":"Z.","family":"Garami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Hascsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dinya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Garai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Damjanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Galuska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2011.09.002_bib1","first-page":"1369","article-title":"A combined PET\/CT scanner for clinical oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2011.09.002_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2422051113","article-title":"PET\/CT: form and function","volume":"242","author":"Blodgett","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2011.09.002_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00702620","article-title":"(18-F) fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer","volume":"15","author":"Minn","year":"1989","journal-title":"Eur J Nuc Med"},{"key":"10.1016\/j.ejso.2011.09.002_bib4","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations","volume":"18","author":"Avril","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002590000448","article-title":"Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures","volume":"28","author":"Schirrmeister","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ejso.2011.09.002_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00259-007-0580-5","article-title":"Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer","volume":"35","author":"Cermik","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2011.09.002_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.semnuclmed.2004.11.001","article-title":"Evolving role of positron emission tomography in breast cancer imaging","volume":"35","author":"Eubank","year":"2005","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ejso.2011.09.002_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bjs.6459","article-title":"Association between [18F] fluorodeoxyglucose uptake and prognostic parameters in breast cancer","volume":"96","author":"Gil-Rendo","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2011.09.002_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10147-010-0120-3","article-title":"Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors","volume":"15","author":"Hendel","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejso.2003.10.010","article-title":"18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer","volume":"30","author":"Zornoza","year":"2004","journal-title":"EJSO"},{"key":"10.1016\/j.ejso.2011.09.002_bib11","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.ejca.2005.04.040","article-title":"Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer","volume":"41","author":"Voogd","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2011.09.002_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Guiliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2011.09.002_bib13","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer","volume":"276","author":"Albertini","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2011.09.002_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12149-009-0314-9","article-title":"Diagnostic performance of fluorodeoxyglucose-positron emission tomography\/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT","volume":"23","author":"Monzawa","year":"2009","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ejso.2011.09.002_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1245\/ASO.2004.11.033","article-title":"A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging patients with early stage breast cancer","volume":"11","author":"Lovrics","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00259-009-1145-6","article-title":"Diagnostic value of full-dose FDG PET\/CT for axillary lymph node staging in breast cancer patients","volume":"36","author":"Heusner","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2011.09.002_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1200\/JCO.2004.04.148","article-title":"Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET sutdy group","volume":"22","author":"Wahl","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00268-009-9955-z","article-title":"Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET\/CT scan in early breast cancer patients: single institutional experience","volume":"33","author":"Kim","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2011.09.002_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2407-8-165","article-title":"Utility of 18F-fluoro-deoxyglucose emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in combination with ultrasonography for axillary staging in primary breast cancer","volume":"8","author":"Ueda","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2011.09.002_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2214\/AJR.05.0936","article-title":"Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review","volume":"186","author":"Alvarez","year":"2006","journal-title":"AJR"},{"key":"10.1016\/j.ejso.2011.09.002_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejso.2011.01.003","article-title":"Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis","volume":"37","author":"Cooper","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15040","article-title":"Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation","volume":"15","author":"Cooper","year":"2011","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ejso.2011.09.002_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejso.2010.10.001","article-title":"Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer","volume":"37","author":"Meng","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann Onc"},{"key":"10.1016\/j.ejso.2011.09.002_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2004.04.021","article-title":"Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan","volume":"60","author":"Farris","year":"2004","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2011.09.002_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1095-0397(00)00042-X","article-title":"The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer","volume":"3","author":"Lonneux","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.ejso.2011.09.002_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1245\/ASO.2006.03.035","article-title":"18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma","volume":"13","author":"Port","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00006231-200209000-00009","article-title":"Comparison of fluorodeoxyglucose positron emission tomography and conventional diagnostic procedures\u2019 for the detection of distant metastases in breast cancer patients","volume":"23","author":"Dose","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2011.09.002_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/annonc\/mdi063","article-title":"Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications","volume":"16","author":"Puglisi","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2011.09.002_bib30","first-page":"1334","article-title":"Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician\u2019s perspective","volume":"42","author":"Yap","year":"2001","journal-title":"J Nucl Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798311005592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798311005592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T01:07:42Z","timestamp":1560647262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798311005592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0748798311005592"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2011.09.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}